Phage-guided modulation of the gut microbiota of mouse models of colorectal cancer augments their responses to chemotherapy

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597

Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients

Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812

Host-gut microbiota metabolic interactions

Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760

Functional interactions between the gut microbiota and host metabolism

Tremaroli, V., & Bäckhed, F. (2012) · Nature · doi:10.1038/nature11552 · Cited by 4,387

Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile

van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708

The gut microbiota, bacterial metabolites and colorectal cancer

Louis, P., Hold, G. L., & Flint, H. J. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3344 · Cited by 2,925

Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment

Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718

Fusobacterium nucleatum Promotes Colorectal Carcinogenesis by Modulating E-Cadherin/β-Catenin Signaling via its FadA Adhesin

Rubinstein, M. R., Wang, X., Liu, W., Hao, Y., Cai, G., & Han, Y. W. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.012 · Cited by 2,476

Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis

Singh, N., Gurav, A., Sivaprakasam, S., Brady, E., Padia, R., Shi, H., Thangaraju, M., Prasad, P. D., Manicassamy, S., Munn, D. H., et al. (2014) · Immunity · doi:10.1016/j.immuni.2013.12.007 · Cited by 2,368

Intestinal inflammation targets cancer-inducing activity of the microbiota

Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263

Fluorescent Peptide Probe for Specific Detection and In Vivo Imaging of Fusobacterium Nucleatum

Wu, H. B., Zhang, B., Lu, Z., Wen, J., Shen, M., Wang, B., Xiong, J., Xu, T., Yang, Z., & Chen, J. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.6c01904 · Cited by 2

The cancer microbiome

Hunter, P. (2023) · EMBO Reports · doi:10.15252/embr.202357040 · Cited by 2

Microbiome therapeutics for the cancer management

Punetha, A., & Punetha, A. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99336-4.00012-4 · Cited by 2

Conversation between host and gut microbiota unveils a “silver bullet” therapeutic option for chemotherapy

Zhang, M., & Guo, H. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.08.008 · Cited by 2

Influence of Intestinal Flora on ICB Therapy for Colorectal Cancer

赵, 飞. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.14123181 · Cited by 2

Targeting breast cancer: the promise of phage-based nanomedicines

Gholami, S., Saffarfar, H., Mehraban, M. R., Ardabili, N. S., Elhami, A., Ebrahimi, S., Ali‐Khiavi, P., Kheradmand, R., Fattahpour, S. F., & Mobed, A. (2025) · Breast Cancer Research and Treatment · doi:10.1007/s10549-025-07696-5 · Cited by 2

Living Cell Materials for Advanced Biomedical Applications in Disease Diagnosis, Treatment, and Prevention

Kong, F., Jiang, J., Chernova, E. A., Wuttke, S., Zhu, W., & Lei, Q. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202502358 · Cited by 2

Building a Better Microbiome: Advances in Microbiome Engineering for Human Health

Munir, S., Aslam, S., Imran, M., Ashfaq, U. A., Ejaz, H., Taqveem, A., & Khurshid, M. (2024) · Springer eBooks · doi:10.1007/978-981-97-3790-1_20 · Cited by 1

Emerging Use of Bacteriophages, Natural Predators of Bacteria, to Combat Antibiotic Resistance in the Clinic and Beyond: A Review of the Field and Biosafety Assessment

Gulig, P. A., Swindle, S., & Eisenman, D. (2025) · Applied Biosafety · doi:10.1177/15356760251388486 · Cited by 1

Circulating tumor DNA methylation and gut microbiota in colorectal cancer: diagnostic, prognostic, and therapeutic implications

Sasaki, K., Emoto, S., Yokoyama, Y., & Ishihara, S. (2026) · International Journal of Clinical Oncology · doi:10.1007/s10147-026-02966-8 · Cited by 1

Targeting Intratumoral Bacteria for Enhanced Tumor Suppression with Nano-Based Therapeutics: A Scoping Review

Yi, T., Dong, Z., & Leung, S. S. Y. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18030318 · Cited by 1

Dynamic reorganisation of intratumoural bacterial florae during colorectal cancer progression

Li, M., Li, Y., Li, C., Liu, A., Liu, Y., Li, Y., Xiao, J., Zhang, D., Jin, Y., Wang, G., et al. (2026) · British Journal of Cancer · doi:10.1038/s41416-026-03344-x · Cited by 1

Analysis of intratumoural bacteria: Opportunities and challenges for cancer therapy

Jiang, X., Zhang, C., Cao, S., Peng, Y., Zhao, M., Zhang, X., & Gao, Y. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.03.022 · Cited by 1

Microbiota as a modulator of drug response: targeting microbial–drug crosstalk in cancer therapy

Zhao, T., Liu, M., Qiu, L. X., Zhang, H., Zhang, N., Liu, Z., Xia, Z., Luo, P., Huang, J., & Cheng, Q. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2651930 · Cited by 1

Chemically mediated modification of bacteriophages: Strategies, functionalities and applications in precision medicine

Hameed, M., Hu, Y., Khan, A., Yu, L., Saghir, A., Hong, W., Liu, J., & Li, P. (2026) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2026.102944 · Cited by 1

Targeting intratumoral bacteria reverses MHC-I suppression and enhances nano-based chemoimmunotherapy in colorectal cancer

Feng, J., Liu, Y.-H., Gong, L.-M., Zhang, W.-X., Liu, C., Xiao, C.-C., Chen, L., Jin, M., Guan, Y.-Y., Gao, Z.-G., et al. (2026) · Military Medical Research · doi:10.1016/j.mmr.2026.100036 · Cited by 1

Artificial intelligence in inflammatory bowel disease: From current evidence, clinical translation, and the road to precision medicine

Hughes, R., Bello, A. L., Liang, R. F.-H., Pugliano, C. L., Zammarchi, I., Ghosh, S., & Iacucci, M. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004170 · Cited by 1

The gut microbiome and colorectal cancer

Dietz, M. A., Subramanian, S., & Staley, C. M. (2026) · Clinical Microbiology Reviews · doi:10.1128/cmr.00332-25 · Cited by 1

Bifidobacterium animalis reshapes the bile acid pool and prevents neonatal jaundice: a clinical microbiome study from correlation to causation

Chen, X., Chen, C., Zhang, P., OuYang, X., Ma, H., Chen, W., Li, T., Han, J., Wang, Y., Wang, H., et al. (2026) · npj Biofilms and Microbiomes · doi:10.1038/s41522-026-01057-w · Cited by 1

IBD-related inflammatory memory and colorectal cancer: epigenetic mechanisms and microbiome interventions

Gao, G., Zhao, X., Lu, X., Yu, S., & Chen, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1912351 · Cited by 1

Bacteriophages-Versatile Tools of The Past and The Future

Smaranda, I. L. (2021) · American Journal of Biomedical Science & Research · doi:10.34297/ajbsr.2021.13.001870 · Cited by 1

Personalized therapy with bacteriophages of digestive diseases

Гончар, Н. В., Ермоленко, К. Д., & Скрипченко, Н. В. (2022) · Journal Infectology · doi:10.22625/2072-6732-2022-14-2-47-54 · Cited by 1

Modulation of tumor environment in colorectal cancer – could gut microbiota be a key player?

Mendes, A. D., Vicente, R. S., Vitorino, M. M., Silva, M., & Costa, D. A. (2022) · Frontiers in Gastroenterology · doi:10.3389/fgstr.2022.1021050 · Cited by 1

Microbiota in Cancer Immunotherapy: The Next Milestone of Immuno-oncology?

Ting, N. L.-N., & Yu, J. (2023) · Springer eBooks · doi:10.1007/978-981-19-4492-5_17 · Cited by 1

Research progress of intestinal microbiota in targeted therapy and immunotherapy of colorectal cancer

Zhou, X., Zhao, Y., Zhao, R., Shafi, S., Yang, Y., Liu, G., & Liu, S. (2024) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2023.178 · Cited by 1

Nanomedicine-Driven Modulation of the Microbiota for Cancer Therapy

Yan, H., Li, Z., Iqbal, A. Z., Cai, J., Zhao, Y., & Li, C. (2025) · ACS Applied Nano Materials · doi:10.1021/acsanm.5c01345 · Cited by 1

In Situ Silver-based Electrochemical Bioreactor In VivoPreprint

Huang, Y. D., Zhong, L., Deng, Z., Wu, P., He, J., Bai, Z., Zhong, Y. P., Peng, H., Zhang, K., Liang, X., et al. (2020) · doi:10.21203/rs.3.rs-103588/v1

Identification of Chemotherapeutic Dihydromyricetin With Enhanced Anti-tumor Activity and Biosafety for Muscle Invasive Bladder CancerPreprint

Wang, Z., Guo, Z., You, W.-J., Wang, W., Zhou, F., Zhang, R., He, Z., Chen, H., & Wang, X. (2021) · Research Square · doi:10.21203/rs.3.rs-763057/v1

The microbiome and cancer

Barrett, M. (2021) · Cork Open Research Archive (University College Cork, Ireland)

Expanding the Genetic Toolkit of Fusobacterium nucleatum by Generation of Fully-Sequenced Genomes and Discovery of Natural Competence

Sanders, B. E. (2020) · VTechWorks (Virginia Tech)

Impact du microbiote intestinal dans les cancers colorectaux

Fidelle, M., Chen, J., Roberti, M. P., Kroemer, G., & Zitvogel, L. (2023) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2023.09.009

Dynamics of the microbiome in pancreatic cancer from inception to invasion

Pfisterer, N. (2023) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-10152

New advances in dietary fibers and their role in metabolic, digestive, and immune health

(2024) · Frontiers research topics · doi:10.3389/978-2-8325-4790-8

Microbiome-Based Therapeutics for the Management of Cancer

Munir, M. U., Javed, I., Butt, M. H., Khan, Y. H., Salman, M., Rehman, Z. U., Khan, F. U., Shamsi, S. S., & Mallhi, T. H. (2024) · Springer eBooks · doi:10.1007/978-981-97-3790-1_14

Research Progress of Intratumoral Microbiota

张, 艺. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1492564

Microbiome and colorectal cancer drug resistance

Miya, T. V., Belancio, V. P., & Dlamini, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-33475-7.00016-0

Bacteriophages: The Natural Combatants to Fight AMR

Mohan, A., Saluja, D., & Bajpai, U. (2024) · Springer eBooks · doi:10.1007/978-981-97-5272-0_15

Cancer and microbiome-targeted therapies

Meena, A. S., Singh, P., & Shukla, P. K. (2025) · International review of cytology · doi:10.1016/bs.ircmb.2024.12.006

Isolation of Bacteriophages Lytic to Fusobacterium necrophorum Subspecies necrophorum from Bovine Ruminal Fluid and City Sewage

Schnur, S. E., Deters, A. K., Gaire, T. N., Volkova, V. V., Biswas, B. K., Thomson, D. U., & Nagaraja, T. G. (2025) · Applied Biosciences · doi:10.3390/applbiosci4010010

Chemotherapeutic dihydromyricetin with remarkable anti-tumor activity and biosafety for muscle invasive bladder cancer.

Guo, Z., Wang, W., Hu, W., You, W., & Wang, Z. (2025) · Europe PMC (PubMed Central) · doi:10.3389/fphar.2025.1609354

Bacteriophages in Cancer Treatment

Üstündağ, M., & Ustundag, B. (2025) · Current Cancer Therapy Reviews · doi:10.2174/0115733947396384250812072136

The function and mechanisms of gut microbiota in the treatment of colorectal cancer: from fundamental to clinical application

Lai, J., & Chen, H. (2025) · Scientia Sinica Vitae · doi:10.1360/ssv-2025-0114

Living therapeutics: Colorectal related diseases precision therapy with engineered organisms

Huang, J., Lan, Y., Chen, L., Guan, X., Liang, R., Liang, J., Gao, M., Gan, J., Guo, Y., & Zhang, S. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.112151

Additional file 6 of Elucidating the genotoxicity of Fusobacterium nucleatum-secreted mutagens in colorectal cancer carcinogenesis

Xu, W., Zhang, Y., Chen, D., Huang, D., Zhao, Y., Hu, W., Lin, L., Liu, Y., Wang, S., Zeng, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.27123751

Additional file 3 of Elucidating the genotoxicity of Fusobacterium nucleatum-secreted mutagens in colorectal cancer carcinogenesis

Xu, W., Zhang, Y., Chen, D., Huang, D., Zhao, Y., Hu, W., Lin, L., Liu, Y., Wang, S., Zeng, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.27123742

Additional file 5 of Elucidating the genotoxicity of Fusobacterium nucleatum-secreted mutagens in colorectal cancer carcinogenesis

Xu, W., Zhang, Y., Chen, D., Huang, D., Zhao, Y., Hu, W., Lin, L., Liu, Y., Wang, S., Zeng, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.27123748

Additional file 4 of Elucidating the genotoxicity of Fusobacterium nucleatum-secreted mutagens in colorectal cancer carcinogenesis

Xu, W., Zhang, Y., Chen, D., Huang, D., Zhao, Y., Hu, W., Lin, L., Liu, Y., Wang, S., Zeng, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.27123745

Additional file 1 of Elucidating the genotoxicity of Fusobacterium nucleatum-secreted mutagens in colorectal cancer carcinogenesis

Xu, W., Zhang, Y., Chen, D., Huang, D., Zhao, Y., Hu, W., Lin, L., Liu, Y., Wang, S., Zeng, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.27123736

Additional file 2 of Elucidating the genotoxicity of Fusobacterium nucleatum-secreted mutagens in colorectal cancer carcinogenesis

Xu, W., Zhang, Y., Chen, D., Huang, D., Zhao, Y., Hu, W., Lin, L., Liu, Y., Wang, S., Zeng, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.27123739

Antimicrobial alternatives to control pathogens involved in liver abscesses, food safety and mastitis in cattle

Schnur, S. E. (2021) · K-State Research Exchange (Kansas State University)

Bacterial Association Networks from Healthy and Cancer-associated Gut Microbiomes

Loftus, M. (2021) · Journal of International Crisis and Risk Communication Research

Biomarker Role in Drug Delivery: Microbiota Implications and Nanotechnology for Personalized Therapeutics

Dinu, L.-D., Vamanu, E., & Avram, I. (2025) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-95-2104-3_7

Overcoming delivery hurdles in phage therapy: The role of nanotechnology

Liu, S., Zhang, H., Pan, Z., Wang, N., Jin, C., & Wu, N. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108081

Microbiota-driven immunometabolic regulation in colorectal cancer: Mechanisms and therapeutic opportunities

Luan, W.-Y., Zhang, S.-P., Xu, K.-Z., Shang, Y.-H., Hu, W., Sun, H., & Miao, Y. (2026) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v18.i3.115722

The Role of the Microbiota in the Carcinogenesis and Progression of Squamous Cell Carcinoma: A Multi-Omic Investigation of Oral and Lung Tumours

Licata, A. G. (2026) · Open Research Online (The Open University) · doi:10.21954/ou.ro.00109330

Etude de l’association du microbiote intestinal et des caractéristiques de composition corporelle sur les résultats postopératoires du cancer colorectal sporadique non métastatique

Véziant, J. (2022) · theses.fr (ABES) · doi:10.70675/1855993az0fd7z47c8zad70zf1885c7261aa

Modulating commensal microbiota: shifting from broad <?A3B2 pi6?>interventions to precision control

Yu, W., & Zheng, D. (2026) · Scientia Sinica Vitae · doi:10.1360/ssv-2025-0417

Microbiota and metabolites modulation of cancer stem cells and chemotherapy sensitivity

Fang, F., Lau, H. C.-H., & Yu, J. Q. (2026) · Gut · doi:10.1136/gutjnl-2026-338801

Dynamic interactions between the oral pathobiont Campylobacter concisus and the human gut microbiota

Sedhai, P., & Istivan, T. S. (2026) · Microbiology Australia · doi:10.1071/ma26121

Current therapeutic interventions for immune dysregulation induced by gut microbiota

Khatami, F., Karimian, S., & Mohammadipanah, F. (2026) · European journal of medical research · doi:10.1186/s40001-026-04579-3

The role of gut microbiota in cancer development and translational modulation strategies

Bai, X., Kang, X., & Wong, S. H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40306-4.00017-x

Targeting tumor-associated bacteria in digestive system cancers: carcinogenic mechanisms and nano-regulate platform design

Liu, H., Wang, X., Xi, Q., Li, T., Huang, H., Zhao, J. Q., Guan, L., & Liu, F. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04720-8

Metabolism-Driven Modulation by the Human Microbiota: Implications for Cancer Therapy and Emerging Strategies

Gouveia, L., Serpa, J., & Mendes, C. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-12166-0_3

Aging and the Microbiome: precondition for gastrointestinal carcinogenesis

Wizenty, J., & Sigal, M. (2026) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2026.102122

From microbial detection to immune profiling: Analytical strategies for Fusobacterium nucleatum in colorectal cancer and liver metastasis

Zu, D., Zhu, Y., Ma, Z., Xie, J., Chen, W., Chen, Y., Chen, G., Yao, Q., Chen, W., & Xu, C. (2026) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2026.119040

Oral microbiome contribution in colorectal carcinogenesis: polymicrobial interactions and virulence determinants

Glazunova, E. V., Astakhova, L., Kurnosov, A., Doludin, Y. V., Lyundup, A., Kostin, A., Makarov, V., Yudin, S., & Zlobovskaya, O. A. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1887826

Targeting tumor metabolism through precision nutrition: A therapeutic strategy to improve cancer outcomes

Chattopadhyay, D., Saha, A., Tendulkar, D., Banerjee, T., Roy, S., Choudhury, L., Rajendran, R. L., Gangadaran, P., & Ahn, B. (2026) · World Journal of Clinical Oncology · doi:10.5306/wjco.124767

Targeting intratumor microbiota in oral squamous cell carcinoma from potential mechanisms to future opportunities

Zhai, Y., Sun, Z., Zhang, S., & Zhao, T. (2026) · Discover Oncology · doi:10.1007/s12672-026-05697-4

The intratumoral microbiome in solid cancers: Spatial ecology, functional crosstalk and translational horizons

Chen, L., Bian, G., Qi, F., Cao, Y., Liao, X., Li, Q., Liang, H., Zhao, Z., Liu, X., Hoang, B. H., et al. (2026) · The Innovation Medicine · doi:10.59717/j.xinn-med.2026.100242

Biomimetic delivery systems for overcoming drug resistance in gastrointestinal cancers

Wu, G., Li, A.-X., Gu, Y.-W., Cheng, X.-L., Mao, R.-C., Wang, X.-J., He, M.-Y., Chai, Q., Li, F.-N., Liu, H., et al. (2026) · Drug Resistance Updates · doi:10.1016/j.drup.2026.101465

Role of pks + Escherichia coli in colorectal cancer: Mechanisms, clinical evidence, and therapeutic perspective

Nasrollahian, S., Halaji, M., Bakeshloo, P. H., Abdullah, M., & Chang, Y.-F. (2026) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2026.106003

Progress in regulating cell-cell communication to enhance immunotherapy

Qu, X., Shu, Y., Ren, J., & Qu, X. (2026) · Scientia Sinica Chimica · doi:10.1360/ssc-2026-0141

Platelet-phage conjugates for targeted therapy of acute bacterial pneumonia

Chen, X., Xie, A., Yang, Y., Jiao, Y., Li, J., Bai, X., You, J., Han, Q., Sheng, T., Wang, S., et al. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124564

Gut Microbiome Modulation for Colorectal Cancer Therapy: Biomolecule‐Integrated Nanotherapeutic Strategies

Sarkar, P., Shannigrahi, S., Sen, O., Adak, S., Jana, P., & Manna, S. (2026) · ChemistrySelect · doi:10.1002/slct.202507043

Bacteriophages as emerging modulators of antitumor immunity in the tumor microenvironment

Chen, X., Zhang, J., Gao, F., & Du, H. (2026) · Microbiological Research · doi:10.1016/j.micres.2026.128700

Human microbiota in cancer: Mechanistic insights, microbial dysbiosis, and emerging microbiome-targeted therapeutic strategies

Panda, P., Mohanty, S., & Mohapatra, R. (2026) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2026.08.003

Beyond antimicrobials: Ecological nano‐strategies for rebalancing dysbiotic oral microbial homeostasis

Hu, C., Luan, A., Yang, Y., Wang, L., Wang, H., Wang, N., He, G., Yang, Y., Noor, R., Hussain, J., et al. (2026) · BMEMat · doi:10.1002/bmm2.70135

Unraveling the bidirectional interplay of the gut microbiota with chemotherapy and radiotherapy in colorectal cancer: from pathogenesis to probiotic interventions

Huang, K., Liang, G., Jiang, L., 智, 庆., Fang, B., Wu, M., Chen, X., & Huang, H. (2026) · Future Microbiology · doi:10.1080/17460913.2026.2720339

Microbiome-Based Therapies: Phage Intervention

Hadi, J. L., Thaqi, A., Ammann, J., Mirzaei, M. K., & Deng, L. (2026) · Springer eBooks · doi:10.1007/978-3-032-26410-7_23

Microbial Signals in Cancer: Dissecting Host–Microbiota–Tumor Interactions and Potential Therapeutic Strategy

Lu, J., Xuan, M., Yu, L., Xie, Z., Chu, Q., Wei, S., Wang, T., Xue, C., & Li, L. (2026) · MedComm · doi:10.1002/mco2.70994

Intratumoral microbiota: implications for colorectal cancer pathogenesis and therapy

Liu, J., & Qi, Z. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1832875

Perspective Chapter: Microbiome Predictive Value for Immunotherapy Response

Gales, L. N., Ghencea, I. A., Serban, E. C., & Trifanescu, O. G. (2026) · Pharmaceutical science. · doi:10.5772/intechopen.1017715

Bacteriophages in humans: From discovery and mechanisms to therapeutic promise in combating disease

Yuan, X., Li, N., Zhu, S., & Zuo, T. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004296

A responsive hybrid metal-organic framework reverses tumor chemotherapy resistance via biological metabolism-guided targeting and sonodynamic therapy-mediated eradication of intratumoral bacteria

Chen, B., Zhang, Y., Gao, Y., Dai, X., & Song, E. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.182163

Nanozymes in Tumor Microenvironment Modulation for Cancer Therapy

Zhang, X., Wang, Z., Niu, Y., Tong, J., Wang, R., Zhu, Y., Pei, P., Li, J., Gao, Y., Deng, X., et al. (2026) · Biomaterials Research · doi:10.34133/bmr.0425

The bidirectional relationship between gut microbiota and the development of colorectal cancer

Li, S., Wang, J., Zhang, L., 杨, 鹏., Wang, J., Yan, C., Chen, D., Huang, Y., & 戴迟兵 (2026) · Current Proteomics · doi:10.1016/j.curpro.2026.100163

Gut microbiome-shaped chemotherapy responses across cancer types: mechanisms of resistance, biomarkers, and targeted interventions

Shao, T., Li, M., Li, S., Pu, J., Li, C., & Guo, C. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1945287

The Microbiome in Glioblastoma: Mechanisms, Tumor–Immune Interactions, and Translational Perspectives

AlRamadneh, T. N., Jyothi‐S, R., Priyadarshini‐Nayak, P., Nanda, A., Al-Hasnaawei, S., Bhatt, A., Chauhan, A. S., Singla, S., & Mishra, M. K. (2026) · MicrobiologyOpen · doi:10.1002/mbo3.70431

Perspective Chapter: The Cancer Microbiome: Mechanisms of Oncogenesis, Tumor Progression and Therapeutic Response – Part 1

Missaoui, N. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1017577

Systemic regulation and precision intervention of the gut microbiome in immunotherapy for gastrointestinal cancers

ZHANG, Y.-F., Ran, X. U. E., & Lin, S. H. E. N. (2026) · Shengming kexue · doi:10.3724/cbls.2026124

Harnessing tumor-associated microbiota for cancer therapy and diagnosis: Mechanisms and engineering strategies

Mei, J., Imin, I., Gao, X., Xue, Y., Xu, K., Zhu, M., Bai, R., & Liu, Y. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.09.033

Microbial-derived metabolites in cancer: evidence boundaries, immune mechanisms and translational pathways

Shi, X., Wang, S., & Ouyang, W. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1947330

Emerging non-antibiotic strategies for combating intracellular pathogens

Yu, Y., & Zhang, X. (2026) · Materials Today · doi:10.1016/j.mattod.2026.103530

Towards recombinant phage-based manipulation of the gut microbiome to treat Inflammatory Bowel Diseases

Lincetto, C. (2023) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.32732

The microbiome-metabolome axis in colorectal cancer therapy resistance: mechanisms, mediators, and therapeutic opportunities

Khan, A., Tareen, A., Farid, A. A. M., Amin, A., Khan, H. N., Hadi, D. K., Khan, S. R., & Raza, A. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1985675

Phages Enter the Fight against Colorectal Cancer

Kannen, V., Parry, L., & Martin, F. L. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.08.002 · Cited by 19

Phage-boosted chemotherapy

Aggarwal, N., Hwang, I. Y., & Chang, M. W. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0450-z · Cited by 3

Phage warriors

Dart, A. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0203-z · Cited by 4

Combination gut microbiota modulation and chemotherapy for orthotopic colorectal cancer therapy

Chen, Z., Li, J.-L., Pan, P., Bao, P., Zeng, X., & Zhang, X. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101329 · Cited by 31

Exploring the therapeutic potential of bacteriophage-mediated modulation of gut microbiota towards colorectal cancer

Kenneth, M. J., Chen, J., Fang, C., Tsai, H., Wu, C., Hsu, T.-K., Chen, C., & Hsu, B. (2025) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2025.107585 · Cited by 6